Recombinant Proteins
Product List
CSDC2 Human
Cold Shock Domain Containing C2 Human Recombinant
ORAOV1 Human
Oral Cancer Overexpressed 1 Human Recombinant
ORAOV1 is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
ORC6 Human
Origin Recognition Complex, Subunit 6 Human Recombinant
ORC6 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
CSN2 Human
Casein Beta Human Recombinant
CSN2 is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
CSRP2 Human
Cysteine and Glycine-rich Protein 2 Human Recombinant
CSRP2 is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
CSTF1 Human
Cleavage Stimulation Factor 1 Human Recombinant
CSTF1 is fused to an 8 amino acid His-tag at C-terminus & purified by proprietary chromatographic techniques.
CSTF1 Human, sf9
Cleavage Stimulation Factor 1 Human Recombinant, sf9
CSTF1 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 437 amino acids (1-431a.a.) and having a molecular mass of 49.1kDa (Molecular size on SDS-PAGE will appear at approximately 40-57kDa).
CSTF1 is expressed with a 6 amino acids His tag at C-Terminus and purified by proprietary chromatographic techniques.
CTBP1 Human
C-Terminal Binding Protein 1 Human Recombinant
CTBP1 is purified by proprietary chromatographic techniques.
CTNNBIP1 Human
Catenin, Beta Interacting Protein 1 Human Recombinant
CTNNBIP1 Recombinant E.coli produced in E.Coli is a single, non-glycosylated polypeptide chain containing 101 amino acids (1-81 a.a.) and having a molecular mass of 11.3 kDa. The CTNNBIP1 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.
ctxB
Cholera Toxin B subunit Recombinant
Cholera Toxin B subunit Recombinant produced in E.Coli is a single, non- glycosylated polypeptide chain containing 103 amino acids and having a molecular mass of 11.6kDa.
ctxB is purified by proprietary chromatographic techniques.
Escherichia Coli.
Sterile filtered colorless solution.
Introduction
The term “Other” can be defined in various contexts. In a general sense, it refers to something or someone that is different or distinct from the one already mentioned or known . In biological taxonomy, classification involves organizing living organisms into hierarchical categories based on their characteristics and evolutionary history .
Biological properties of “Other” can be understood through key characteristics shared by living organisms, such as order, sensitivity or response to stimuli, reproduction, growth and development, regulation, homeostasis, and energy processing . These properties are expressed in various patterns and distributed across different tissues, contributing to the organism’s overall function and survival.
The primary biological functions of “Other” include catalyzing chemical reactions, synthesizing and repairing DNA, transporting materials across cells, receiving and sending chemical signals, responding to stimuli, and providing structural support . These functions play crucial roles in immune responses and pathogen recognition, ensuring the organism’s defense mechanisms are active and effective .
Modes of action describe the functional or anatomical changes resulting from exposure to a substance. This includes the interaction with other molecules and cells, binding partners, and downstream signaling cascades . For example, a mode of action could involve binding to DNA, leading to transcriptional regulation .
Regulatory mechanisms control the expression and activity of “Other” through transcriptional regulation and post-translational modifications . These mechanisms ensure that the biological processes are carried out efficiently and accurately, adapting to the organism’s needs and environmental changes.
In biomedical research, “Other” has various applications, including diagnostic tools and therapeutic strategies . For instance, understanding the biological properties and functions of different molecules can lead to the development of new treatments and diagnostic methods, improving healthcare outcomes.
